NCT01003392

Brief Summary

Coffee is a worldwide drink, been part of any culture. There are some concerns about effects of coffee on the health. Recently, epidemiological studies have shown benefits of coffee drinking to diabetics and also to prevent diabetes in populations. We aim to understand some effects of coffee and not only caffeine over vascular system, in special coronary artery disease patients, diabetics end normal people.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2008

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

October 26, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 28, 2009

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

January 7, 2014

Status Verified

January 1, 2014

Enrollment Period

6.8 years

First QC Date

October 26, 2009

Last Update Submit

January 6, 2014

Conditions

Keywords

Coronary artery diseaseCoffeeHeart system

Outcome Measures

Primary Outcomes (1)

  • Verify the relationship between coffee ingestion and cardiovascular morbidity and mortality

    10 years of follow-up

Secondary Outcomes (1)

  • Relationship between coffee ingestion and cardiovascular risk factors

    10 years

Study Arms (3)

Normal

Normal volunteers, with no diagnosed chronic disease.

Coronary artery disease

Group of patients with diagnosed coronary artery disease.

Diabetes

Diabetic patients.

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Group of normal patients, group of patients with diagnosed coronary artery disease and group of diabetic patients.

You may qualify if:

  • Normal Volunteers:
  • Healthy volunteer.
  • Age between 20 and 80 years.
  • No addict to drugs.
  • Absence of chronicle diseases.
  • No alcohol abuse.
  • No smoker.
  • Coronary artery disease:
  • Presence of coronary artery disease, by coronary angiography
  • Stable angina, class 1-3 of CCS.
  • Age between 20 and 80 years.
  • Treadmill effort test with ischemia.
  • No alcohol abuse.
  • No smoker.
  • Diabetes:
  • +5 more criteria

You may not qualify if:

  • Normal Volunteers:
  • Any blood test with twice or more the upper limit range.
  • Presence of enlarged QRS.
  • Coronary artery disease:
  • Any blood test with twice or more the upper limit range even with treatment.
  • Presence of enlarged QRS.
  • Ventricular dysfunction (EF \< 45%).
  • Diabetes:
  • Blood glucose greater than 160 mg/dL.
  • Others blood tests with twice or more the upper limit range even with treatment.
  • Presence of enlarged QRS.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Heart Institute (InCor), Univ. of Sao Paulo Medical School

São Paulo, São Paulo, 05403000, Brazil

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples.

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Luiz A Machado Cesar, PhD, MD.

    Heart Institute

    STUDY CHAIR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

October 26, 2009

First Posted

October 28, 2009

Study Start

March 1, 2008

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

January 7, 2014

Record last verified: 2014-01

Locations